Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
---|---|---|---|---|---|
C5A-C51H9 | Cynomolgus | Cynomolgus Complement C5a Protein, His Tag |
|
||
C5A-H51H9 | Human | Human Complement C5a Protein, His Tag |
|
||
C5A-H525a | Human | Human Complement C5a Protein, Fc Tag (MALS verified) |
|
||
C5A-C5118 | Cynomolgus | Cynomolgus Complement C5a Protein, Tag Free |
|
||
C5A-M51H4 | Mouse | Mouse Complement C5a Protein, His Tag |
|
||
C5A-H5116 | Human | Human Complement C5a Protein, Tag Free |
|
Immobilized Human Complement C5a, His Tag (Cat. No. C5A-H51H9) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-Human C5a Human Antibody, Human IgG1 with a linear range of 0.1-4 ng/ml (QC tested).
The purity of Human Complement C5a, Fc Tag (Cat. No. C5A-H525a) is more than 90% and the molecular weight of this protein is around 80-90 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Vilobelimab | CaCP-29; IFX-1 | Phase 3 Clinical | Inflarx Nv | Granulomatosis with Polyangiitis; Shock, Septic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Drug-Related Side Effects and Adverse Reactions; Microscopic Polyangiitis; Pyoderma Gangrenosum; Sepsis; Coronavirus Disease 2019 (COVID-19); Lung Diseases, Interstitial; Hidradenitis Suppurativa; Systemic Inflammatory Response Syndrome | Details |
BDB-001 | BDB-1; BDB-001; BDB001; BDB 001 | Phase 3 Clinical | Staidson(Beijing) Biopharmaceuticals Co Ltd | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Coronavirus Disease 2019 (COVID-19); Hidradenitis Suppurativa | Details |
STSA-1002 | STSA-1002; STSA1002 | Phase 2 Clinical | Staidson(Beijing) Biopharmaceuticals Co Ltd | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult | Details |
Vilobelimab | CaCP-29; IFX-1 | Phase 3 Clinical | Inflarx Nv | Granulomatosis with Polyangiitis; Shock, Septic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Drug-Related Side Effects and Adverse Reactions; Microscopic Polyangiitis; Pyoderma Gangrenosum; Sepsis; Coronavirus Disease 2019 (COVID-19); Lung Diseases, Interstitial; Hidradenitis Suppurativa; Systemic Inflammatory Response Syndrome | Details |
BDB-001 | BDB-1; BDB-001; BDB001; BDB 001 | Phase 3 Clinical | Staidson(Beijing) Biopharmaceuticals Co Ltd | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Coronavirus Disease 2019 (COVID-19); Hidradenitis Suppurativa | Details |
STSA-1002 | STSA-1002; STSA1002 | Phase 2 Clinical | Staidson(Beijing) Biopharmaceuticals Co Ltd | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult | Details |
This web search service is supported by Google Inc.